Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

The Risk of Venous Thrombosis for Erythropoiesis Stimulating Agents and Blood Transfusions in Cancer Patients: A Nationwide Population-Based Study in Korea

Byung-Hyun Lee, Yeonju Yu, Se Ryeon Lee, Yong Park, Hwa Jung Sung, Byung Soo Kim

Blood (2023) 142 (Supplement 1): 1270.

https://doi.org/10.1182/blood-2023-188620

Published: 2023

Journal Articles

Real-World Efficacy of Eculizumab for Paroxysmal Nocturnal Hemoglobinuria in South Korea: Paradox of Eculizumab

Ka-Won Kang, Hyemi Moon, Byung-Hyun Lee, MD, Min Ji Jeon, Eun Sang Yu, MD, Dae Sik Kim, Se Ryeon Lee, Hwa Jung Sung, Seok Jin Kim, MD PhD, Chul Won Choi, Byung Soo Kim, Juneyoung Lee, Yong Park

Blood (2019) 134 (Supplement_1): 2227.

https://doi.org/10.1182/blood-2019-125269

Published: 2019

Journal Articles

Survival Benefit with Standard-Dose Decitabine Versus Standard-Dose Azacitidine in Patients with Lower-Risk Myelodysplastic Syndromes

Byung-Hyun Lee, MD, Ka-Won Kang, MD, Min Ji Jeon, MD, Eun Sang Yu, MD, Dae Sik Kim, MD PhD, Hojoon Choi, MD, Se Ryun Lee, MD PhD, Hwa Jung Sung, MD PhD, Yong Park, MD, Chul Won Choi, MD PhD, Byung Soo Kim, MD PhD

Blood (2018) 132 (Supplement 1): 3099.

https://doi.org/10.1182/blood-2018-99-115694

Published: 2018

Journal Articles

One-Day Low-Dose Etoposide Is an Effective Chemomobilization Regimen with Minimal Toxicity for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: A Multicenter Study from Tertiary Hospitals in Korea

Yong Park, MD, Dae Sik Kim, MD PhD, Ka-Won Kang, MD, Byung-Hyun Lee, MD, Eun Sang Yu, MD, Min Ji Jeon, MD, Hojoon Choi, MD, Se Ryeon Lee, MD PhD, Hwa Jung Sung, MD PhD, Chul Won Choi, MD PhD, Kihyun Kim, MD PhD, Byung Soo Kim, MD PhD, Seok Jin Kim, MD PhD

Blood (2018) 132 (Supplement 1): 3347.

https://doi.org/10.1182/blood-2018-99-115625

Published: 2018

Journal Articles

Immature Platelet Fraction Based Diagnostic Predictive Model for Immune Thrombocytopenic Purpura

Min Ji Jeon, MD, Hojoon Choi, MD, Eun Sang Yu, MD, Ka-Won Kang, MD, Byung-Hyun Lee, MD, Dae Sik Kim, MD PhD, Yong Park, MD, Se Ryeon Lee, MD PhD, Hwa Jung Sung, MD PhD, Chul Won Choi, MD PhD, Byung Soo Kim, MD PhD

Blood (2018) 132 (Supplement 1): 1149.

https://doi.org/10.1182/blood-2018-99-117754

Published: 2018

Journal Articles

The Potential of Exosomes Derived from Chronic Myelogenous Leukemia Cells As Biomarker Based on the BCR-ABL mRNA Transcript

Ka-Won Kang, MD, Jik-han Jung, Woojune Hur, Jaena Park, Hyunku Shin, ByeongHyeon Choi, Hyesun Jeong, Dae Sik Kim, MD PhD, Eun Sang Yu, MD, Se Ryeon Lee, MD PhD, Hwa Jung Sung, MD PhD, Seok Jin Kim, MD PhD, Chul Won Choi, MD PhD, Byung Soo Kim, MD PhD, Hyun Koo Kim, MD PhD, Sunghoi Hong, PhD, Ji-ho Park, PhD, Yeonho Choi, PhD, Yong Park, MD PhD

Blood (2017) 130 (Supplement 1): 2883.

https://doi.org/10.1182/blood.V130.Suppl_1.2883.2883

Published: 2017

Journal Articles

Routine Imaging for Surveillance in Patients with Aggressive Non-Hodgkin Lymphoma in Complete Remission after Frontline Chemotherapy

Ka-Won Kang, MD, Dae Sik Kim, MD PhD, Eun Sang You, MD, Yong Park, MD PhD, Se Ryeon Lee, Hwa Jung Sung, MD PhD, Seok Jin Kim, Chul Won Choi, MD PhD, Byung Soo Kim

Blood (2016) 128 (22): 3041.

https://doi.org/10.1182/blood.V128.22.3041.3041

Published: 2016

Journal Articles

Impact of G-CSF for Outcomes of Non-M3 AML Patients Who Were Treated By Anthracycline-Based Induction (7+3 regimen) Chemotherapies

Ka-Won Kang, MD, Yong Park, MD PhD, Dae Sik Kim, MD PhD, Se Ryeon Lee, MD PhD, Hwa Jung Sung, MD PhD, Seok Jin Kim, MD PhD, Chul Won Choi, MD PhD, Byung Soo Kim, MD PhD

Blood (2015) 126 (23): 4889.

https://doi.org/10.1182/blood.V126.23.4889.4889

Published: 2015

Journal Articles

High-Dose Cytarabine Alone Versus Cytarabine Plus Anthracycline for Consolidation Therapy in Non-Promyelocytic Acute Myeloid Leukemia

Sung-Hyun Kim, So Yeon Kim, Ji Hyun Lee, MD PhD, Suee Lee, Sung Yong Oh, Hyo-Jin Kim, Dae Sik Kim, MD, Ka-Won Kang, MD, Se Ryeon Lee, MD PhD, Yong Park, MD PhD, Hwa Jung Sung, MD PhD, Chul Won Choi, MD PhD, Byung Soo Kim, MD PhD

Blood (2015) 126 (23): 4890.

https://doi.org/10.1182/blood.V126.23.4890.4890

Published: 2015

Journal Articles

High-Dose Cytarabine Consolidation (≥1.5 g/m 2 ) Might Have Shown a Better Outcomes Than Intermediate-Dose Cytarabine (1.0 g/m 2 ) Combined With Anthracyclines In AML Patients Who Had Achieved Complete Remissions In The First Induction by Standard 3+7 Regimen

Yong Park, MD, PhD, Ga-won Kang, MD, Dae Sik Kim, MD, Suk-young Lee, MD, Ph.D, Se Ryeon Lee, MD, PhD, Hwa Jung Sung, Chul Won Choi, MD, PhD, Seok Jin Kim, MD, PhD, Myunghyun Nam, MD, PhD, Ji-Seon Choi, MD, PhD, Soo-Young Yoon, MD, PhD, Byung Soo Kim, Insun Kim, MD, PhD

Blood (2013) 122 (21): 2692.

https://doi.org/10.1182/blood.V122.21.2692.2692

Published: 2013

Journal Articles

Sustained Long-Term MMR to a Reduced Dose of Imatinib in Chronic-Phase CML: A Pilot Study of SLC22A1 Gene Polymorphisms

Se Ryeon Lee, MD, PhD, Seok Young Lee, MD, Dae Sik Kim, MD, Yong Park, MD, Hwa Jung Sung, Chul Won Choi, MD, Jae Sook Ahn, MD, Deok-Hwan Yang, MD, PhD, Byung Soo Kim, MD, PhD

Blood (2012) 120 (21): 4449.

https://doi.org/10.1182/blood.V120.21.4449.4449

Published: 2012

Journal Articles

The Results of Chemotherapy for the Elderly Acute Myelogenous Leukemia Patients

Daesik Kim, MD, Yong Park, MD, Suk-young Lee, MD, Ph.D, Se Ryeon Lee, M.D., Ph.D., Hwa Jung Sung, Seok Jin Kim, MD, Byung Soo Kim, Chulwon Choi, MD

Blood (2012) 120 (21): 4346.

https://doi.org/10.1182/blood.V120.21.4346.4346

Published: 2012

Journal Articles

Treatment Outcomes and Prognostic Factors of Ifosfamide, Etoposide, Cytarabine, Methotrexate, and Dexamethasone (IVAMdex) Regimen As 3 rd Line (2 nd salvage) Chemotherapy in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma

Yong Park, Seh Jong Park, Seok Young Lee, Se Ryeon Lee, Hwa Jung Sung, Seok Jin Kim, MD, PhD, Chul Won Choi, MD, PhD, Byung Soo Kim

Blood (2011) 118 (21): 2685.

https://doi.org/10.1182/blood.V118.21.2685.2685

Published: 2011

Journal Articles

Pretreatment Serum Level of 15-KDa Granulysin Might Predict Recurrence and Survival of Diffuse Large B Cell Lymphoma Patients Treated by R-CHOP Regimen

Yong Park, Yoon Ji Choi, Se Jong Park, Se Ryeon Lee, Hwa Jung Sung, Kyong Hwa Park, Seok Jin Kim, MD, PhD, Chul Won Choi, Byung Soo Kim, Kwang Yoon Jung

Blood (2010) 116 (21): 1993.

https://doi.org/10.1182/blood.V116.21.1993.1993

Published: 2010

Journal Articles

Changes in Serum Protein Profiles During Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT): Clinical Significance of Serum C-Reactive Protein and Haptoglobin Levels.

Se Ryeon Lee, Joohyun Ryu, Jae-Sook Ahn, Yeo-Kyeoung Kim, Deok Hwan Yang, Je-Jung Lee, Hwa Jung Sung, Chul Won Choi, Byung Soo Kim, Byoung Chul Park, Hyeoung-Joon Kim

Blood (2009) 114 (22): 4658.

https://doi.org/10.1182/blood.V114.22.4658.4658

Published: 2009

Journal Articles

Effects of Reduced Dose of Imatinib to Korean Chrionic Myeloid Leukemia in Chronic Phase.

Se Ryeon Lee, Yong Park, Hee Yun Seo, Hwa Jung Sung, Seok Jin Kim, In keun Choi, Chul Won Choi, Byung Soo Kim

Blood (2009) 114 (22): 4290.

https://doi.org/10.1182/blood.V114.22.4290.4290

Published: 2009

Journal Articles

Bilateral Optic Nerve Invasion of Extranodal Marginal Zone B Cell Lymphoma with Leukemic Subtype

Hwa Jung Sung, MD, PhD, Eui Bae Kim, MD, Se Ryeon Lee, MD, PhD, Kyong Hwa Park, MD, PhD, In Keun Choi, MD, PhD, Sang Chul Oh, MD, PhD, Byung Soo Kim, MD, PhD, Yeul Hong Kim, MD, PhD, Jun Suk Kim, MD, PhD, Hee Yun Seo, MD, Sun Hyung Kim, MD, Soo-Young Yoon, MD, PhD

Blood (2008) 112 (11): 5285.

https://doi.org/10.1182/blood.V112.11.5285.5285

Published: 2008

Journal Articles

Mitoxantrone, Etoposide, and Intermediate-Dose Cytarabine in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia : Single-Center Experience

Hwa Jung Sung, MD, PhD, Eui Bae Kim, MD, Se Ryeon Lee, MD, PhD, Hee Yun Seo, MD, Kyong Hwa Park, MD, PhD, In keun Choi, MD, PhD, Sang Chul Oh, MD, PhD, Chul Won Choi, MD, PhD, Byung Soo Kim, MD, PhD, Yeul Hong Kim, MD, PhD, Jun Suk Kim, MD, PhD

Blood (2008) 112 (11): 4007.

https://doi.org/10.1182/blood.V112.11.4007.4007

Published: 2008

Journal Articles

Serum B-Cell Activating Factor (BAFF) in Diffuse Large B-Cell Lymphoma: Its Prognostic Significance in the Rituximab Era.

Seok Jin Kim, MD, PhD, Hwa Jung Sung, MD, PhD, Chul Won Choi, MD, PhD, In Sun Kim, MD, PhD, Byung Soo Kim, MD, PhD, Soo-Young Yoon, MD, PhD, Jong-Ho Won, MD, PhD, Jun Suk Kim, MD, PhD

Blood (2007) 110 (11): 1575.

https://doi.org/10.1182/blood.V110.11.1575.1575

Published: 2007

NARROW

The Risk of Venous Thrombosis for Erythropoiesis Stimulating Agents and Blood Transfusions in Cancer Patients: A Nationwide Population-Based Study in Korea

Real-World Efficacy of Eculizumab for Paroxysmal Nocturnal Hemoglobinuria in South Korea: Paradox of Eculizumab

Survival Benefit with Standard-Dose Decitabine Versus Standard-Dose Azacitidine in Patients with Lower-Risk Myelodysplastic Syndromes

One-Day Low-Dose Etoposide Is an Effective Chemomobilization Regimen with Minimal Toxicity for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: A Multicenter Study from Tertiary Hospitals in Korea

Immature Platelet Fraction Based Diagnostic Predictive Model for Immune Thrombocytopenic Purpura

The Potential of Exosomes Derived from Chronic Myelogenous Leukemia Cells As Biomarker Based on the BCR-ABL mRNA Transcript

Routine Imaging for Surveillance in Patients with Aggressive Non-Hodgkin Lymphoma in Complete Remission after Frontline Chemotherapy

Impact of G-CSF for Outcomes of Non-M3 AML Patients Who Were Treated By Anthracycline-Based Induction (7+3 regimen) Chemotherapies

High-Dose Cytarabine Alone Versus Cytarabine Plus Anthracycline for Consolidation Therapy in Non-Promyelocytic Acute Myeloid Leukemia

High-Dose Cytarabine Consolidation (≥1.5 g/m 2 ) Might Have Shown a Better Outcomes Than Intermediate-Dose Cytarabine (1.0 g/m 2 ) Combined With Anthracyclines In AML Patients Who Had Achieved Complete Remissions In The First Induction by Standard 3+7 Regimen

Sustained Long-Term MMR to a Reduced Dose of Imatinib in Chronic-Phase CML: A Pilot Study of SLC22A1 Gene Polymorphisms

The Results of Chemotherapy for the Elderly Acute Myelogenous Leukemia Patients

Treatment Outcomes and Prognostic Factors of Ifosfamide, Etoposide, Cytarabine, Methotrexate, and Dexamethasone (IVAMdex) Regimen As 3 rd Line (2 nd salvage) Chemotherapy in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma

Pretreatment Serum Level of 15-KDa Granulysin Might Predict Recurrence and Survival of Diffuse Large B Cell Lymphoma Patients Treated by R-CHOP Regimen

Changes in Serum Protein Profiles During Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT): Clinical Significance of Serum C-Reactive Protein and Haptoglobin Levels.

Clinical Features and Treatment Outcomes of Non-Hodgkin's Lymphoma with Breast Involvement; Multi-Institutional Analysis of 98 Patients in Korea.

Effects of Reduced Dose of Imatinib to Korean Chrionic Myeloid Leukemia in Chronic Phase.

Bilateral Optic Nerve Invasion of Extranodal Marginal Zone B Cell Lymphoma with Leukemic Subtype

Mitoxantrone, Etoposide, and Intermediate-Dose Cytarabine in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia : Single-Center Experience

Serum B-Cell Activating Factor (BAFF) in Diffuse Large B-Cell Lymphoma: Its Prognostic Significance in the Rituximab Era.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only